Crystal Gustin
Optometrist · Lafayette, LANPI 1073891024
Payments from drug & device makers
Across 61 payments — averaging $82.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$3K
- Alcon$263
- Biotissue Holdings Inc.$263
- AbbVie$224
- Glaukos Corporation$158
- Tarsus Pharmaceuticals, Inc.$154
- plus $625 from 9 others
What the payments were for
- Speaking & faculty fees$2,52050%
- Food & beverage$2,39047%
- Education$982%
- Entertainment$321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 23 | $3,352 |
| Alcon | 9 | $263 |
| Biotissue Holdings Inc. | 5 | $263 |
| AbbVie(2 entities) | 6 | $224 |
| Glaukos Corporation | 2 | $158 |
| Tarsus Pharmaceuticals, Inc. | 3 | $154 |
| Mallinckrodt Hospital Products Inc. | 3 | $152 |
| Oyster Point Pharma, Inc. | 3 | $125 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $123 |
| Sun Pharmaceutical Industries Inc. | 1 | $98 |
| Dompe US, Inc. | 1 | $35 |
| Optos, Inc. | 1 | $32 |
| Novartis | 1 | $26 |
| Sight Sciences, Inc. | 1 | $21 |
| Carl Zeiss Meditec, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MyDay Contact Lens$1,126
- Multiple Brands Contact Lens$500
- Tecnis IOL$246
- KXL System$151
- Photrexa$151
- VUITY$109
- Prokera$106
- AmnioGraft$106
- XDEMVY$103
How this compares
$5,040 in reported general payments places this provider in the 85th percentile of 500 optometrist providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 43 | $585 |
| Timolol Maleate | 18 | $155 |
| Brimonidine Tartrate | 13 | $32 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 11 | $21 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Lafayette
- Leanne GilderLafayette$8K
- Laurie SicardLafayette$7K
- Mitchell BroussardLafayette$6K
- Joseph AtkinsLafayette$6K
- Catherine GuidryLafayette$5K
- Pamela TheriotShreveport$207K
- Joshua DavidsonGonzales$189K
- Jeffrey WilhiteMarrero$86K
- Christopher WrotenHammond$59K
- James LamarNew Orleans$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.